Iovance reports progress with custom cell therapies for solid tumors - STAT

Iovance reports progress with custom cell therapies for solid tumors - STAT

STAT Plus: Iovance reports progress with its custom cell therapies for solid tumors

By ADAM FEUERSTEIN

MATTHEW DANIELS/WELLCOME

Two bespoke cell therapies developed by Iovance Biotherapeutics are inducing durable tumor responses in patients with advanced melanoma and cervical cancer.

READ MORE